Aging

Showing 1-1 of 1

Accelerating Medicines Partnership® Program for Alzheimer's Disease (AMP® AD)

Accelerating Alzheimer's Research and Drug Development

The Accelerating Medicines Partnership® Program for Alzheimer's Disease (AMP® AD) is a precompetitive partnership among government, industry, and nonprofit organizations to transform the current model for developing new diagnostics and treatments for Alzheimer's disease.

Accelerating Medicines Partnership (AMP)

Scientific Contacts for AMP AD

Laurie Ryan, Ph.D.
Email Laurie Ryan